Rego Payment Architectures (RPMT) 10-Q8 Nov 132013 Q3 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2013	Nov. 08, 2013
Document and Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Entity Registrant Name	'VIRTUAL PIGGY, INC.	'
Entity Central Index Key	'0001437283	'
Current Fiscal Year End Date	'--12-31	'
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2013	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	111,396,768

Balance_Sheets

Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
CURRENT ASSETS	'	'
Cash and cash equivalents	$4,583,551	$7,371,036
Accounts Receivable	955	53
Insurance receivable	'	75,000
Prepaid expenses	200,771	20,500
TOTAL CURRENT ASSETS	4,785,277	7,466,589
PROPERTY AND EQUIPMENT	'	'
Computer equipment	99,156	70,149
Furniture and fixtures	53,714	46,130
Gross property and equipment	152,870	116,279
Less: accumulated depreciation	-40,054	-19,580
Total property and equipment	112,816	96,699
OTHER ASSETS	'	'
Deposit	63,510	65,000
Patents and trademarks, net of accumulated amoritization of $33,295 and $13,678	604,572	362,496
Total other assets	668,082	427,496
TOTAL ASSETS	5,566,175	7,990,784
CURRENT LIABILITIES	'	'
Accounts payable and accrued expenses	1,393,206	704,602
Litigation settlement	'	450,000
TOTAL CURRENT LIABILITIES	1,393,206	1,154,602
CONTINGENCIES	'	'
STOCKHOLDERS' EQUITY	'	'
Preferred stock, $.0001 par value; 2,000,000 shares authorized; none issued and outstanding at September 30, 2013 and December 31, 2012	'	'
Common stock, $ .0001 par value; 150,000,000 shares authorized; 111,386,768 and 101,417,508 shares issued and outstanding at September 30, 2013 and December 31, 2012	11,140	10,142
Common stock subscribed	'	50,000
Common stock subscription receivable	'	-50,000
Additional paid in capital	35,002,330	26,300,114
Deficit accumulated during the development stage	-30,840,501	-19,474,074
STOCKHOLDERS' EQUITY	4,172,969	6,836,182
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$5,566,175	$7,990,784

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Balance Sheets [Abstract]	'	'
Patents and trademarks, accumulated amoritization	$33,295	$13,678
Preferred stock, par value per share	$0.00	$0.00
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$0.00	$0.00
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	111,386,768	101,417,508
Common stock, shares outstanding	111,386,768	101,417,508

Statements_of_Operations

Statements of Operations (USD $)	3 Months Ended		9 Months Ended		68 Months Ended
Statements of Operations (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Statements of Operations [Abstract]	'	'	'	'	'
SALES	$1,382	$8	$1,528	$1,195	$6,667
OPERATING EXPENSES	'	'	'	'	'
Payroll	1,515,701	886,215	3,912,056	1,740,952	7,072,125
Consulting	1,034,270	242,116	1,931,801	4,422,241	10,235,480
Marketing	1,462,861	143,484	2,037,589	463,109	2,903,912
Research and development	179,476	188,717	612,958	356,096	2,024,710
Travel	274,088	121,344	717,931	365,481	2,158,412
Professional fees	256,296	118,724	652,303	361,036	2,255,260
General and administrative	587,343	320,052	1,512,798	871,823	3,683,571
Total operating expenses	5,310,035	2,020,652	11,377,436	8,580,738	30,333,470
OTHER INCOME (EXPENSE)	'	'	'	'	'
Interest income	3,167	1,910	9,481	3,448	18,136
Interest expense	'	'	'	-90,560	-531,834
Total other income (expense)	3,167	1,910	9,481	-87,112	-513,698
NET LOSS	($5,305,486)	($2,018,734)	($11,366,427)	($8,666,655)	($30,840,501)
BASIC AND DILUTED NET LOSS PER COMMON SHARE	($0.05)	($0.02)	($0.11)	($0.11)	'
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING	111,372,435	91,599,649	106,477,739	82,087,967	'

Statement_of_Changes_in_Stockh

Statement of Changes in Stockholders' Equity (Deficit) (USD $)	Total	Common Stock [Member]	Common Stock Subscribed [Member]	Common Stock Subscription Receivable [Member]	Additional Paid-In Capital [Member]	Deficit Accumulated During the Development Stage [Member]
Balance, values at Feb. 10, 2008	'	'	'	'	'	'
Balance, shares at Feb. 10, 2008	'	'	'	'	'	'
Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, values	19,000	1,900	'	'	17,100	'
Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, shares	'	19,000,000	'	'	'	'
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, values	250,000	714	'	'	249,286	'
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, shares	'	7,142,858	'	'	'	'
Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values	8,825	'	'	'	8,825	'
Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values	107,859	'	'	'	107,859	'
Exercise of options on May 8, 2008, at $.04 per share, values	20,000	50	'	'	19,950	'
Exercise of options on May 8, 2008, at $.04 per share, shares	'	500,000	'	'	'	'
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, values	232,500	665	'	'	231,835	'
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, shares	'	6,642,858	'	'	'	'
Options issued for services in June 2008, vested immediately and valued at $.07 per share, values	395,467	'	'	'	395,467	'
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values	918	'	'	'	918	'
Issuance of shares of common stock to investors in August 2008 at $1.00 per share, values	2,560	'	'	'	2,560	'
Issuance of shares of common stock to investors in August 2008 at $1.00 per share, shares	'	2,560	'	'	'	'
Exercise of options in September 2008 at $.04 per share, values	70,000	175	'	'	69,825	'
Exercise of options in September 2008 at $.04 per share, shares	'	1,750,000	'	'	'	'
Exercise of warrants in September 2008 at $.04 per share, values	10,000	25	'	'	9,975	'
Exercise of warrants in September 2008 at $.04 per share, shares	'	250,000	'	'	'	'
Net loss	-983,886	'	'	'	'	-983,886
Balance, values at Dec. 31, 2008	133,243	3,529	'	'	1,113,600	-983,886
Balance, shares at Dec. 31, 2008	'	35,288,276	'	'	'	'
Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values	37,506	'	'	'	37,506	'
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values	636	'	'	'	636	'
Exercise of options on January 26, 2009 at $.04 per share, values	40,000	100	'	'	39,900	'
Exercise of options on January 26, 2009 at $.04 per share, shares	'	1,000,000	'	'	'	'
Issuance of shares of common stock on April 7, 2009 at $1.00 per share, values	400,000	40	'	'	399,960	'
Issuance of shares of common stock on April 7, 2009 at $1.00 per share, shares	'	400,000	'	'	'	'
Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, values	200,000	10	'	'	199,990	'
Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, shares	'	100,000	'	'	'	'
Exercise of options on July 30, 2009 at $.04 per share, values	40,000	100	'	'	39,900	'
Exercise of options on July 30, 2009 at $.04 per share, shares	'	1,000,000	'	'	'	'
Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values	10,462	'	'	'	10,462	'
Exercise of warrants on August 21, 2009 at $.04 per share, values	40,000	100	'	'	39,900	'
Exercise of warrants on August 21, 2009 at $.04 per share, shares	'	1,000,000	'	'	'	'
Exercise of options on September 2, 2009 at $.04 per share, values	20,000	50	'	'	19,950	'
Exercise of options on September 2, 2009 at $.04 per share, shares	'	500,000	'	'	'	'
Issuance of shares of common stock on September 17, 2009 at $1.00 per share, values	100,000	10	'	'	99,990	'
Issuance of shares of common stock on September 17, 2009 at $1.00 per share, shares	'	100,000	'	'	'	'
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, values	1,080,427	108	'	'	1,080,319	'
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, shares	'	1,080,427	'	'	'	'
Issuance of shares of common stock on October 16, 2009 at $1.00 per share, values	100,000	10	'	'	99,990	'
Issuance of shares of common stock on October 16, 2009 at $1.00 per share, shares	'	100,000	'	'	'	'
Exercise of warrants on October 22, 2009 at $.04 per share, values	40,000	100	'	'	39,900	'
Exercise of warrants on October 22, 2009 at $.04 per share, shares	'	1,000,000	'	'	'	'
Exercise of warrants on December 2, 2009 at $.04 per share, values	40,000	100	'	'	39,900	'
Exercise of warrants on December 2, 2009 at $.04 per share, shares	'	1,000,000	'	'	'	'
Exercise of options on December 10, 2009 at $.04 per share, values	10,000	25	'	'	9,975	'
Exercise of options on December 10, 2009 at $.04 per share, shares	'	250,000	'	'	'	'
Exercise of warrants on December 31, 2009 at $.04 per share, values	40,000	100	'	'	39,900	'
Exercise of warrants on December 31, 2009 at $.04 per share, shares	'	1,000,000	'	'	'	'
Stock issuance costs	-65,000	'	'	'	-65,000	'
Net loss	-2,236,476	'	'	'	'	-2,236,476
Balance, values at Dec. 31, 2009	30,798	4,382	'	'	3,246,778	-3,220,362
Balance, shares at Dec. 31, 2009	'	43,818,703	'	'	'	'
Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values	27,899	'	'	'	27,899	'
Exercise of options on January 5, 2010 at $.04 per share, values	40,000	100	'	'	39,900	'
Exercise of options on January 5, 2010 at $.04 per share, shares	'	1,000,000	'	'	'	'
Exercise of warrant on February 22, 2010 at $.04 per share, values	35,713	89	'	'	35,624	'
Exercise of warrant on February 22, 2010 at $.04 per share, shares	'	892,858	'	'	'	'
Exercise of warrants in March 2010 at $.04 per share, values	40,000	100	'	'	39,900	'
Exercise of warrants in March 2010 at $.04 per share, shares	'	1,000,000	'	'	'	'
Exercise of warrants in April 2010 at $.04 per share, values	100,000	250	'	'	99,750	'
Exercise of warrants in April 2010 at $.04 per share, shares	'	2,500,000	'	'	'	'
Issuance of shares of common stock in conjunction with notes payable in May through August 2010, values	400,742	48	'	'	400,694	'
Issuance of shares of common stock in conjunction with notes payable in May through August 2010, shares	'	483,750	'	'	'	'
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, values	'	6	'	'	-6	'
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, shares	'	65,000	'	'	'	'
Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, values	1,925,000	963	'	'	1,924,037	'
Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, shares	'	9,625,000	'	'	'	'
Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, values	75,000	38	'	'	74,962	'
Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, shares	'	375,000	'	'	'	'
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, values	100,000	11	'	'	99,989	'
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, shares	'	111,111	'	'	'	'
Exercise of options on December 2, 2010 at $.04 per share, values	120,000	300	'	'	119,700	'
Exercise of options on December 2, 2010 at $.04 per share, shares	'	3,000,000	'	'	'	'
Exercise of warrants in December 2010 at $.04 per share, values	100,000	250	'	'	99,750	'
Exercise of warrants in December 2010 at $.04 per share, shares	'	2,500,000	'	'	'	'
Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values	13,816	'	'	'	13,816	'
Net loss	-1,489,190	'	'	'	'	-1,489,190
Balance, values at Dec. 31, 2010	1,519,778	6,537	'	'	6,222,793	-4,709,552
Balance, shares at Dec. 31, 2010	'	65,371,422	'	'	'	'
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, values	49,000	10	'	'	48,990	'
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, shares	'	100,000	'	'	'	'
Issuance of shares of common stock in conjunction with notes payable from September through December 2011, value	82,665	15	'	'	82,650	'
Issuance of shares of common stock in conjunction with notes payable from September through December 2011, shares	'	150,000	'	'	'	'
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, values	500,000	125	'	'	499,875	'
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, shares	'	1,250,000	'	'	'	'
Issuance of warrants in conjunction with notes payable from September through December 2011	20,930	'	'	'	20,930	'
Fair value of revalued warrants at $.09 to $.76 per share	88,601	'	'	'	88,601	'
Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values	3,146	'	'	'	3,146	'
Nonemployee options issued for services on January 24, 2011, vested immediately and valued at $.20 per share	46,019	'	'	'	46,019	'
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share	52,243	'	'	'	52,243	'
Net loss	-2,724,796	'	'	'	'	-2,724,796
Balance, values at Dec. 31, 2011	-362,414	6,687	'	'	7,065,247	-7,434,348
Balance, shares at Dec. 31, 2011	'	66,871,422	'	'	'	'
Stock issuance costs	-28,000	'	'	'	-28,000	'
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, values	7,086,932	2,044	'	'	7,084,888	'
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, shares	'	20,426,948	'	'	'	'
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, values	1,050,000	262	'	'	1,049,738	'
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, shares	'	2,625,000	'	'	'	'
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, values	3,312,537	136	'	'	3,312,401	'
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, shares	'	1,363,185	'	'	'	'
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, values	200,000	57	'	'	199,943	'
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, shares	'	571,428	'	'	'	'
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values	297,500	35	'	'	297,465	'
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, shares	'	350,000	'	'	'	'
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, values	5,560,000	794	'	'	5,559,206	'
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, shares	'	7,942,858	'	'	'	'
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, values	500,000	67	'	'	499,933	'
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, shares	'	666,667	'	'	'	'
Exercise of options on April 10, 2012 at $.04 per share, values	10,000	25	'	'	9,975	'
Exercise of options on April 10, 2012 at $.04 per share, shares	'	250,000	'	'	'	'
Exercise of options on May 25, 2012 at $.04 per share, values	14,000	35	'	'	13,965	'
Exercise of options on May 25, 2012 at $.04 per share, shares	'	350,000	'	'	'	'
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share, values	2,219	'	'	'	2,219	'
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values	759,292	'	'	'	759,292	'
Nonemployee options issued for services on January 2012 through December 2012, vesting over three years and valued at$. 17 to $.40 per share, values	39,751	'	'	'	39,751	'
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 To $.53 per share, values	283,460	'	'	'	283,460	'
Employee options issued for services from January 2012 through December 2012, vesting immediately and valued at $.14 to $.42 per share, values	150,631	'	'	'	150,631	'
Common stock subscription for 62,500 units through private placement at $.80 per unit	'	'	50,000	-50,000	'	'
Net loss	-12,039,726	'	'	'	'	-12,039,726
Balance, values at Dec. 31, 2012	6,836,182	10,142	50,000	-50,000	26,300,114	-19,474,074
Balance, shares at Dec. 31, 2012	101,417,508	101,417,508	'	'	'	'
Stock issuance costs	-395,221	'	'	'	-395,221	'
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values	34,372	'	'	'	34,372	'
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 To $.53 per share, values	340,173	'	'	'	340,173	'
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, values	50,000	13	'	'	49,987	'
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, shares	'	125,000	'	'	'	'
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, values	850,000	113	'	'	849,887	'
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, shares	'	1,133,334	'	'	'	'
Issuance of shares on April 15, 2013 common stock for services, values	49,071	3	'	'	49,068	'
Issuance of shares on April 15, 2013 common stock for services, shares	'	26,521	'	'	'	'
Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, value	5,170,595	287	'	'	5,170,308	'
Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, shares	'	2,872,553	'	'	'	'
Fair value of revalued options $1.07 per share	780	'	'	'	780	'
Exercise of options at $0.04 per share in May 2013, value	30,000	75	'	'	29,925	'
Exercies of options at $0.04 per share in May 2013, shares	'	750,000	'	'	'	'
Exercise of options at $0.35 per share on May 14, 2013, value	105,000	30	'	'	104,970	'
Exercise of options at $0.35 per share on May 14, 2013, shares	'	300,000	'	'	'	'
Exercise of options at $0.75 per share in May 2013, value	50,000	7	'	'	49,993	'
Exercise of options at $0.75 per share in May 2013, shares	'	66,667	'	'	'	'
Exercise of warrants at $0.04 per share on May 26, 2013, value	80,000	200	'	'	79,800	'
Exercise of warrants at $0.04 per share on May 26, 2013, shares	'	2,000,000	'	'	'	'
Exercise of warrants at $0.50 per share in May through August 2013, value	1,347,593	270	'	'	1,347,323	'
Exercise of warrants at $0.50 per share in May through August 2013, shares	'	2,695,185	'	'	'	'
Nonemployee options/warrants issued for services from January 2013 through September 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share	784,247	'	'	'	784,247	'
Employee options issued for services on January 2013 through September 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share	206,604	'	'	'	206,604	'
Common stock subscription for 62,500 units through private placement at $.80 per unit	'	'	-50,000	50,000	'	'
Net loss	-11,366,427	'	'	'	'	-11,366,427
Balance, values at Sep. 30, 2013	$4,172,969	$11,140	'	'	$35,002,330	($30,840,501)
Balance, shares at Sep. 30, 2013	111,386,768	111,386,768	'	'	'	'

Statement_of_Changes_in_Stockh1

Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) (USD $)

1 Months Ended

3 Months Ended

5 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

3 Months Ended

5 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

4 Months Ended

2 Months Ended

12 Months Ended

2 Months Ended

12 Months Ended

1 Months Ended

4 Months Ended

1 Months Ended

12 Months Ended

3 Months Ended

5 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

Oct. 31, 2009

Sep. 30, 2009

Jun. 30, 2009

Apr. 30, 2009

Feb. 29, 2008

31-May-13

Dec. 31, 2011

Feb. 29, 2008

Mar. 31, 2013

Sep. 30, 2008

Sep. 30, 2012

Dec. 31, 2012

31-May-13

Dec. 31, 2011

Feb. 29, 2008

Mar. 31, 2013

Sep. 30, 2008

Sep. 30, 2012

Dec. 31, 2012

Mar. 31, 2008

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Jan. 31, 2011

Aug. 31, 2009

Jun. 30, 2008

Mar. 31, 2008

Nov. 30, 2010

Aug. 31, 2011

Dec. 31, 2012

Aug. 31, 2011

Dec. 31, 2012

31-May-13

31-May-12

Apr. 30, 2012

Dec. 31, 2010

Jan. 31, 2010

Dec. 31, 2009

Sep. 30, 2009

Jul. 31, 2009

Jan. 31, 2009

Sep. 30, 2008

31-May-08

31-May-13

Jun. 30, 2008

Aug. 31, 2008

31-May-13

Dec. 31, 2010

Apr. 30, 2010

Mar. 31, 2010

Feb. 28, 2010

Dec. 31, 2009

Oct. 31, 2009

Aug. 31, 2009

Sep. 30, 2008

Aug. 31, 2013

Dec. 31, 2009

31-May-12

Jun. 30, 2011

Nov. 30, 2010

Oct. 31, 2009

Dec. 31, 2010

Mar. 31, 2013

Dec. 31, 2010

Dec. 31, 2012

Nov. 30, 2010

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2011

Sep. 30, 2013

Issuance of Shares of Common Stock [Member]

Warrant [Member]

Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]

Employee Options Issued for Services Transaction One [Member]

Employee Options Issued for Services Transaction Two [Member]

Nonemployee Options Issued for Services Transaction One [Member]

Nonemployee Options Issued for Services Transaction Two [Member]

Exercise of Options Transaction One [Member]

Exercise of Options Transaction Two [Member]

Exercise of Options Transaction Three [Member]

Options Issued for Services [Member]

Issuance of Shares of Common Stock to Investors [Member]

Exercise of Warrants Transaction One [Member]

Exercise of Warrants Transaction Two [Member]

Issuance of Shares of Common Stock for Future Services [Member]

Issuance of Shares of Common Stock for Retirement of Options [Member]

Issuance of Shares of Common Stock Through Private Placement Transaction One [Member]

Issuance of Shares of Common Stock Through Private Placement Transaction Two [Member]

Issuance of Shares of Common Stock for Conversion of Notes Payable [Member]

Issuance of Shares of Common Stock and Warrants to Discharge Notes Payable and Accrued Interest [Member]

Issuance of Shares of Common Stock with Respect to Settlement Agreement [Member]

Common Stock Subscription for Units Through Private Placement [Member]

Nonemployee Options/Warrants Issued for Services [Member]

Fair Value of Revalued Warrants [Member]

Fair Value of Revalued Options [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Equity issuance, number securities issued for cash

1,436,277

625,000

14,285,716

93,750

614,286

10,213,474

1,500,000

285,714

Equity issuance, price or exercise price per security issued

$0.00

$1.80

$0.80

$0.04

$0.80

$0.75

$0.70

$0.80

$0.02

$0.22

$0.11

$0.68

$0.53

$0.14

$0.42

$0.20

$0.31

$0.01

$0.02

$0.01

$0.10

$0.11

$0.19

$0.95

$0.17

$0.40

$0.04

$0.35

$0.75

$0.07

$0.04

$0.50

$0.04

$2.43

$0.49

$0.90

$0.25

$0.75

$0.20

$0.70

$0.75

$0.70

$0.85

$0.80

$0.09

$1.66

$0.09

$0.76

$1.07

Retirement of options, shares

400,000

Conversion of notes payable, price per share

$0.20

Units subscribed

62,500

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	9 Months Ended		68 Months Ended
Statements of Cash Flows (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
Net loss	($11,366,427)	($8,666,655)	($30,840,501)
Adjustments to reconcile net loss to net cash used in operating activities	'	'	'
Fair value of warrants issued in exchange for services	549,915	'	638,516
Fair value of options issued in exchange for services	816,261	478,350	2,756,411
Fair value of stock issued in exchange for services	49,071	3,312,537	4,791,035
Amortization of deferred costs	'	'	78,243
Accretion of discount on notes payable	'	65,560	426,095
Depreciation and amortization	40,091	15,818	73,349
Provision for bad debt	'	'	42,768
Loss on disposal of fixed assets	'	'	2,726
(Increase) decrease in assets	'	'	'
Accounts receivable	-902	1,125	-955
Insurance receivable	75,000	'	'
Other receivable	'	'	-42,768
Prepaid expenses	-180,271	-23,735	-200,771
Deposits	1,490	-62,233	-63,510
Increase (decrease) in liabilities	'	'	'
Accounts payable and accrued expenses	238,602	346,561	1,715,704
Net cash used in operating activities	-9,777,170	-4,532,672	-20,623,658
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Purchase of equipment	-36,591	-93,975	-155,595
Patent and trademark costs	-261,693	-198,388	-637,868
Net cash used in investing activities	-298,284	-292,363	-793,463
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Proceeds from note payable - stockholders	'	'	747,500
Repayment of note payable - stockholders	'	-175,000	-572,500
Proceeds from notes payable	'	'	75,000
Proceeds from issuance of common stock	6,070,595	7,936,932	23,796,584
Proceeds from exercise of options	185,000	24,000	569,000
Proceeds from exercise of warrants	1,427,595	'	1,873,309
Stock issuance costs	-395,221	-28,000	-488,221
Net cash provided by financing activities	7,287,969	7,757,932	26,000,672
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	-2,787,485	2,932,897	4,583,551
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	7,371,036	186,159	'
CASH AND CASH EQUIVALENTS - END OF PERIOD	4,583,551	3,119,056	4,583,551
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:	'	'	'
Income taxes paid	'	'	'
Interest paid	'	'	2,498
Fair value of common stock issued as discount for notes payable	'	'	483,409
Conversion of notes payable and accrued interest into common stock	'	200,000	75,000
Fair value of warrants issued as discount for notes payable	'	'	20,930
Issuance of common stock for settlement of payable	'	'	$297,500

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Nature of the Business
	Virtual Piggy, Inc. ("the Company" or "Virtual Piggy") is a development stage enterprise incorporated in the state of Delaware on February 11, 2008. Virtual Piggy is a technology company that delivers an online e-commerce solution for the family. Its system allows parents and their children to manage and allocate funds and track the child's expenditures, savings and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent's permission ahead of time and allowing the parent to set up the rules of use and authorized spending limits.

	The Virtual Piggy product enables online businesses to interact and transact with the "Under 18" market in a manner consistent with the Children's Online Privacy Protection Act ("COPPA") and other similar international children's privacy laws. Virtual Piggy was launched in the US in 2012 and was launched in the European market in 2013.

	The Company has secured 143 agreements with merchants, retail and gaming e-commerce platforms and payment processors. Over 20 of the merchants are using Virtual Piggy live with their e-commerce systems and the Company is in the process of integrating the other signed merchants. The Company is continuing to add merchants. In addition, Virtual Piggy has the capability to offer and deliver digital gift cards.

	Basis of Presentation
	The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.

	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

	Comprehensive Income
	The Company follows FASB ASC 220 in reporting comprehensive income. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since the Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).

	Fair Value of Financial Instruments
	The Company's financial instruments consist of cash, accounts receivable and accounts payable and accrued expenses. The carrying value of cash, accounts receivable and accounts payable and accrued expenses approximate fair value, because of their short maturity.

	Concentration of Credit Risk Involving Cash
	The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance coverage of $250,000.

	Cash and Cash Equivalents
	For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.

	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation and any impairment losses. Expenditures for new equipment and major expenditures for existing equipment are capitalized and depreciated using the straight line method at rates sufficient to depreciate such costs over the estimated productive lives. All other ordinary repair and maintenance costs are expensed as incurred.

	The Company's depreciation and amortization policies on property and equipment are as follows:


		Useful life
		(in years)

	Computer equipment	3 - 5
	Furniture and fixtures	7

	Recoverability of Long-Lived Assets
	In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 360-10-35 "Impairment or Disposal of Long-lived Assets", long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable or that the useful lives of those assets are no longer appropriate. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment.

	The Company determines the existence of such impairment by measuring the expected future cash flows (undiscounted and without interest charges) and comparing such amount to the carrying amount of the assets. An impairment loss, if one exists, is then measured as the amount by which the carrying amount of the asset exceeds the discounted estimated future cash flows. Assets to be disposed of are reported at the lower of the carrying amount or fair value of such assets less costs to sell. Asset impairment charges are recorded to reduce the carrying amount of the long-lived asset that will be sold or disposed of to their estimated fair values. Charges for the asset impairment reduce the carrying amount of the long-lived assets to their estimated salvage value in connection with the decision to dispose of such assets.

	For the nine month period ended September 30, 2013 and 2012, the Company determined that no impairment was required after going through the impairment testing related to the operating long-lived assets (property and equipment and patents and trademarks).

	Revenue Recognition
	In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale utilizing Virtual Piggy payment method at checkout.

	Income Taxes
	The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.

	Loss Per Share
	The Company follows FASB ASC 260 when reporting earnings per share resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss for the three and nine months ended September 30, 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same.

	Start-up Costs
	In accordance with FASB ASC 720, start-up costs are expensed as incurred.

	Research and Development Costs
	In accordance with FASB ASC 730, research and development costs are expensed when incurred.

	Recently Adopted Accounting Pronouncements
	As of September 30, 2013 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted
As of September 30, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

Reclassifications
Certain amounts in the 2012 financial statements have been reclassified in order for them to be in conformity with the 2013 presentation.

GOING_CONCERN

GOING CONCERN	9 Months Ended
GOING CONCERN	Sep. 30, 2013
GOING CONCERN [Abstract]	'
GOING CONCERN	'
	NOTE 2 - GOING CONCERN

	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant losses and experienced negative cash flow from operations during the development stage. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

	Since inception, the Company has focused on developing and implementing its business plan. The Company is paying salaries to management and has utilized offshore programmers on a work for hire basis to assist in developing the demonstration model. The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months. The Company currently needs to generate revenue in order to sustain its operations. In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities. The issuance of additional equity would result in dilution to existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.

	The Company's current monetization model is to derive a percentage of all revenues generated by online merchants using the Virtual Piggy service. Merchants are billed at the end of each month for all transactions that have been processed by the Company on their behalf in the prior month. As the merchant base and consumer base grows, and as the trend to higher online spending levels continues, the Company expects to generate additional revenue to support operations.

	If sufficient revenues are not generated to sustain operations or additional funding cannot be obtained in the short term, the Company will need to reduce monthly expenditures to a level that will enable the Company to continue until such funds can be obtained. The Company raised $6,070,595, net of stock issuance costs of $395,221 through a private placements of its equity securities from January 1, 2013 through September 30, 2013.

	The Company also raised $185,000 from the exercise of options and $1,427,595 from the exercise of warrants during the nine months ended September 30, 2013.

	The Company is in the development stage at September 30, 2013. Successful completion of the Company's development program, and the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities and achieving a level of sales adequate to support the Company's cost structure. However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level. The Company's current cash is expected to sustain the Company through December 2013.

PATENTS

PATENTS	9 Months Ended
PATENTS	Sep. 30, 2013
PATENTS [Abstract]	'
PATENTS	'
	NOTE 3 - PATENTS

	The Company continues to apply for patents. Accordingly, costs associated with the registration of these patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents (20 years). At September 30, 2013 and 2012, unamortized capitalized patent costs were $604,572 and $268,856. Amortization expense for patents was $7,718 and $19,617 for the three and nine months ended September 30, 2013 and $3,374 and $7,546 for the three and nine months ended September 30, 2012.

NOTES_PAYABLE

NOTES PAYABLE	9 Months Ended
NOTES PAYABLE	Sep. 30, 2013
NOTES PAYABLE [Abstract]	'
NOTES PAYABLE	'
	NOTE 4 - NOTES PAYABLE

	In September 2011, the Company commenced a private placement of up to 10 units at a price of $50,000 per unit to accredited investors. One unit consisted of a demand note payable in the amount of $50,000 due November 12, 2012, warrants to purchase 15,000 shares of common stock at an exercise price of $.50 per share with a term expiring November 12, 2012, and 15,000 shares of common stock. In December 2011, the Company completed the private placement and raised $500,000. The warrants were valued at $20,930, fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 39.8% to 62.8%, risk free interest rate of .1% and expected option life of 1.2 years. The shares of common stock were valued at $82,655 or $.45 to $.70 per share, fair value. Both the warrant value and the shares of common stock were treated as a discount to the value of the note payable in accordance with FASB ASC 835-30-25, Recognition and were being accreted over the term of the note payable for financial statement purposes. During the years ended December 31, 2012 and 2011, $65,560 and $38,035 of interest was accreted on the notes payable. As of December 31, 2011, $150,000 of the $500,000 was repaid.

	On February 8, 2012, February 27, 2012, and April 10, 2012, $100,000, $50,000, and $25,000 respectively, of the notes payable were repaid. On April 26, 2012, the remaining balance of the notes payable and accrued interest of $25,000 was converted into 571,428 shares of the Company's common stock and warrants to purchase 285,714 shares of the Company's common stock.

INCOME_TAXES

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2013
INCOME TAXES [Abstract]	'
INCOME TAXES	'
	NOTE 5 - INCOME TAXES

	Income tax expense was $0 for the three and nine months ended September 30, 2013 and 2012.

	As of January 1, 2013, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2013 related to unrecognized tax benefits. There has been no change in unrecognized tax benefits during the nine months ended September 30, 2013, and there was no accrual for uncertain tax positions as of September 30, 2013. Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.

	There is no income tax benefit for the losses for the three and nine months ended September 30, 2013 and 2012, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.

LITIGATION_SETTLEMENT

LITIGATION SETTLEMENT	9 Months Ended
LITIGATION SETTLEMENT	Sep. 30, 2013
LITIGATION SETTLEMENT [Abstract]	'
LITIGATION SETTLEMENT	'
	NOTE 6 - LITIGATION SETTLEMENT

	In December 2012, the Company entered into a settlement agreement with an investor, whereby the Company would pay the investor $450,000 in return for the investor returning warrants issued to the investor. The Company received $75,000 from its insurance carrier with respect to this litigation and the $450,000 settlement was paid in January 2013.

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
STOCKHOLDERS' EQUITY	Sep. 30, 2013
STOCKHOLDERS' EQUITY [Abstract]	'
STOCKHOLDERS' EQUITY	'
	NOTE 7 - STOCKHOLDERS' EQUITY

	In December 2011, the Company commenced a private placement of up to $5,000,000 consisting of up to 12,500,000 shares of the Company's common stock and warrants to purchase up to 6,250,000 shares of the Company's common stock. The shares and warrants were sold in units with each unit comprised of two shares and one warrant at a purchase price of $.80 per unit. The warrants were for a term of two years at an exercise price of $0.50 per share. During December 2011, the Company sold 625,000 units and raised $500,000. On January 11, 2012, the Company amended the Securities Purchase Agreement dated December 1, 2011, by reducing the price of one unit from $.80 to $.70. This increased the number of units to be sold from 6,250,000 units to 7,142,858 units. It also required the Company to issue to one investor an additional 89,286 units, consisting of 178,572 shares common stock and warrants to purchase an additional 89,286 shares of common stock. During the three months ended March 31, 2012, the Company issued an additional 3,922,356 units and raised $2,717,650, net of stock issuance costs of $28,000.

	On April 5, 2012, the Company commenced a private placement of up to $3,500,000 consisting of up to 10,000,000 shares of the Company's common stock and warrants to purchase up to 5,000,000 shares of the Company's common stock at an exercise price of $.50 per share. The shares and warrants were sold in units with each unit comprised of two shares and one warrant at a purchase price of $.70 per unit. The warrants were for a term of two years. In accordance with the terms of the offering documents, the offering amount was increased to $4 million. From April 5, 2012 to June 30, 2012, the Company sold 6,201,831 units and raised $4,341,282.

	On April 2, 2012, the Company entered into a settlement agreement with a former consultant of the Company. In connection with the settlement, the Company made a settlement payment to the consultant of $30,000 and issued the consultant 350,000 shares of the Company's common stock, which were valued at $297,500, fair value, or $.85 per share.

	On April 10, 2012, a company owned by the Secretary of the Company and his wife exercised options to purchase 250,000 shares of common stock which raised proceeds of $10,000.

	On May 2, 2012, the Company entered into a securities purchase agreement with a non-U.S. person, pursuant to which the Company issued and sold 187,500 units at a purchase price of $0.80 per unit, in consideration of gross proceeds of $150,000. Each unit consisted of: (i) two shares of the Company's common stock, (ii) a warrant to purchase one share of the Company's common stock at an exercise price of $0.50 per share for a term of two years, and (iii) a warrant to purchase one half share of the Company's common stock at an exercise price of $1.00 per share for a term of three years. Pursuant to the securities purchase agreement, the purchaser also agreed to purchase an additional $850,000 of units by November 1, 2012. The Company has received $1,000,000 as of March 31, 2013 under this agreement.

	On May 21, 2012, the Company issued five consultants an aggregate of 1,363,185 shares of the Company's common stock for services, which were valued in the aggregate at $3,312,537, fair value or $2.43 per share, which was the stock price on the day of issuance.

	On May 25, 2012, an investor exercised options to purchase 350,000 shares of common stock which raised proceeds of $14,000.

	On July 5, 2012, the Company commenced a private placement of up to $100,000 consisting of up to 125,000 units of the Company's common stock and warrants to purchase up to 125,000 shares of the Company's common stock at an exercise price of $.50 per share with a term of two years ("Series A Warrants") and warrants to purchase up to 62,500 at an exercise price of $1.00 per share with a term of three years ("Series B Warrants"). The shares and warrants were sold in units with each unit comprised of two shares and one Series A warrant and one Series B warrant at a purchase price of $.80 per unit. As of August 8, 2012, the Company has received gross proceeds of $100,000 under this private placement.

	During November and December 2012, the Company entered into a private placement for shares of the Company's common stock. The shares were sold at a purchase price of $.70 per share. Through December 31, 2012, 7,942,858 shares were sold raising $5,560,000.

	In December 2012, the Company entered into a private placement for shares of the Company's common stock. The shares were sold at a purchase price of $.75 per share. Through December 31, 2012, 666,667 shares were sold raising $500,000.

	During the first quarter of 2013, the Company entered into a private placement for shares of the Company's common stock. The shares were sold at a purchase price of $.75 per share. Through March 31, 2013, 1,133,334 shares were sold raising $850,000. Issuance costs related to this private placement were $60,783.

	On April 15, 2013, the Company issued 26,521 restricted shares of the Company's common stock to five members of the Board of Directors that were valued at $49,071. In conjunction with this the five members of the Board also received in aggregate options to purchase 1,050,000 shares of the Company's common stock. These options were valued at $519,080, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.0%, risk free interest rate of .69% and expected option life of five years. The options expire five years from the date of issuance. Options granted will be expensed over the three year vesting term.

	On May 28, 2013, we entered into a Securities Purchase Agreement with accredited investors, pursuant to which we issued and sold an aggregate of 2,572,553 units at a purchase price of $1.80 per unit (the "Offering"), with each unit being comprised of one (1) share of the Company's common stock and a warrant to purchase one-half (0.5) of a share of common stock at an exercise price of $3.00 per share for a period of three years. On May 29, 2013, we issued and sold an additional 300,000 units pursuant to the Offering. The Company retained a placement agent in connection with the Offering. The Company paid the placement agent aggregate placement agent fees in the amount of $151,408 plus $155,118 as an expense allowance. In addition, the placement agent received three year warrants to purchase an aggregate of 287,255 shares of the Company's common stock at an exercise price of $1.80 per share (See Note 8-Stock Options and Warrants). Net proceeds of the Offering to the Company, after the expense allowance and other expenses, were approximately $4,836,157.

	During May 2013, options to purchase 750,000 shares of common stock were exercised at $0.04 per share, options to purchase 300,000 shares of common stock were exercised at $0.35 per share, and options to purchase 66,667 shares of common stock were exercised at $0.75, resulting in proceeds of $185,000.

	During May and June 2013, warrants to purchase 2,000,000 shares of common stock were exercised at $.04 per share and warrants to purchase 2,660,685 shares of common stock were exercised at $0.50 per share, resulting in proceeds of $1,330,342.

	During July and August 2013, warrants to purchase 34,500 shares of common stock were exercised at $.50 per share, resulting in proceeds of $17,250.

STOCK_OPTIONS_AND_WARRANTS

STOCK OPTIONS AND WARRANTS

9 Months Ended

Sep. 30, 2013

STOCK OPTIONS AND WARRANTS [Abstract]

STOCK OPTIONS AND WARRANTS

NOTE 8 - STOCK OPTIONS AND WARRANTS

During 2008, the Board of Directors ("Board") of the Company adopted the 2008 Equity Incentive Plan ("2008 Plan") that was approved by the shareholders. Under the 2008 Plan, the Company is authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company. The 2008 Plan is intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended ("Incentive Stock Options"). All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options ("Non-Statutory Stock Options"). As of September 30, 2013, options to purchase 14,053,000 shares of common stock have been issued and are unexercised, and 61,667 shares of common stock are available to be issued under the 2008 Plan.

During 2013, Board adopted the 2013 Equity Incentive Plan ("2013 Plan"). Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant. The 2013 Plan is intended to permit, upon stockholder approval, stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options. All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options. As of September 30, 2013, under the 2013 Plan options to purchase 3,702,500 shares of common stock have been issued and are unexercised, and 1,297,500 shares of common stock remain available for grants under the 2013 Plan.

The plans are administered by the Board, or a designated committee thereof, which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the terms of the plans.

In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).

Volatility in all instances presented is the Company's estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company.

Employee and Non-Employee Director Grants

On January 27, 2012, the Company issued an employee an option to purchase 30,000 shares of the Company's common stock at $.52 per share. These options have been valued at $3,718, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.4%, risk free interest rate of 0.8% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

On February 28, 2012, the Company issued an employee an option to purchase 25,000 shares of the Company's common stock at $.58 per share. These options have been valued at $3,120, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.0%, risk free interest rate of .8% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

On March 2, 2012, the Company issued a Board member an option to purchase 250,000 shares of the Company's common stock at $.58 per share. These options have been valued at $33,975, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.9%, risk free interest rate of .9% and expected option life of five years. The options expire five years from the date of issuance. This option was expensed immediately.

On March 5, 2012, the Company issued an employee an option to purchase 25,000 shares of the Company's common stock at $.58 per share. These options have been valued at $2,680, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.0%, risk free interest rate of .9% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

On March 31, 2012, the Company issued five employees, options to purchase 4,010,000 shares in the aggregate of the Company's common stock at $.65 per share. These options have been valued at $759,810, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In April 2012, the Company issued six employees options to purchase an aggregate of 80,000 shares of the Company's common stock at exercise prices ranging from $.65 to $.97 per share. These options were valued at $17,310 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.2% to 33.4%, risk free interest rate of .82% to 1.04% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In June 2012, the Company issued three employees and one Board member options to purchase an aggregate of 470,000 shares of the Company's common stock at exercise prices ranging from $1.53 to $1.82 per share. These options were valued at $217,293, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.3% to 35.5%, risk free interest rate of .68% to .72% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term or immediately if there is no vesting term.

In July 2012, the Company issued one employee options to purchase an aggregate of 15,000 shares of the Company's common stock at an exercise price of $1.23 per share. These options were valued at $5,493 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 32.9%, risk free interest rate of .61% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In August 2012, the Company issued seven employees options to purchase an aggregate of 380,000 shares of the Company's common stock at exercise prices ranging from $1.26 to $1.43 per share. These options were valued at $123,381, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 29.1%, risk free interest rate of .63% to .69% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In September 2012, the Company issued one employee options to purchase 75,000 shares of the Company's common stock at an exercise price of $1.54 per share. These options were valued at $26,303, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.5%, risk free interest rate of .62% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In October 2012, the Company issued one employee options to purchase 75,000 shares of the Company's common stock at an exercise price of $1.35 per share. These options were valued at $23,263 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.5%, risk free interest rate of .70% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In November 2012, the Company issued fourteen employees options to purchase an aggregate of 1,295,000 shares of the Company's common stock at exercise prices between $1.01 and $1.35 per share. These options were valued at $371,313, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 26.1% and 29.3%, risk free interest rate between .76% and .83% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In March 2008, the Company issued options to purchase 4,500,000 shares of common stock to three directors. On January 24, 2013, the expiration date for unexpired and unexercised options of 4,250,000 was extended from March 3, 2013 to March 3, 2015. The incremental increase in value was $1,253, which was expensed immediately.

In January 2013, the Company issued eighteen employees options to purchase an aggregate of 260,000 shares of the Company's common stock at exercise prices between $0.99 and $1.05 per share. These options were valued at $62,662 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 23.3% and 26.1%, risk free interest rate between .78% and .89% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In February 2013, the Company issued four employees options to purchase an aggregate of 760,000 shares of the Company's common stock at exercise prices between $1.07 and $1.21 per share. These options were valued at $199,843 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 22.5% and 25.1%, risk free interest rate between .78% and .88% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In March 2013, the Company issued an employee options to purchase 2,500 shares of the Company's common stock at an exercise price of $1.36 per share. These options were valued at $728 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In April 2013, the Company issued an employee options to purchase 200,000 shares of the Company's common stock at an exercise price of $1.56 per share. These options were valued at $74,159, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.3%, risk free interest rate of .76% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In May 2013, the Company issued two employees options to purchase an aggregate of 55,000 shares of the Company's common stock at an exercise price of $2.16 and $2.29 per share. These options were valued at $26,954, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 25.3%, risk free interest rate of .84% to .85% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In June 2013, the Company issued two employees options to purchase an aggregate of 250,000 shares of the Company's common stock at exercise prices of $2.40 and $2.92 per share. The vesting of 50,000 of these options is predicated on meeting certain milestones, therefore such options have not been valued. The remaining options were valued at $129,343, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.6% to 26.3%, risk free interest rate of 1.03% to 1.48% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In August 2013, the Company issued three employees options to purchase an aggregate of 210,000 shares of the Company's common stock at exercise prices of $2.00 and $2.35 per share. These options were valued at $124,392, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.2% to 30.3%, risk free interest rate of 1.38% to 1.61% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

In September 2013, the Company issued two employees options to purchase an aggregate of 10,000 shares of the Company's common stock at an exercise price of $1.97 per share. These options were valued at $4,500, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 21.8%, risk free interest rate of 1.71% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the three year vesting term.

Cumulatively and for the three and nine months ended September 30, 2013, the Company expensed $1,446,783, $210,380 and $546,776 and for the three and nine months ended September 30, 2012, the Company expensed $81,588 and $274,757 relative to employee options/warrants granted. As of September 30, 2013, there was $1,746,505 of unrecognized compensation expense related to employee non-vested market-based share awards.

A summary of stock option/warrant transactions for employees and independent board members from December 31, 2011 to September 30, 2013 is as follows:

Weighted Average

Option/Warrants

Exercise

Price

Outstanding, December 31, 2011

9,467,858

$.04 to $.90

0.19

Granted

6,730,000

0.50 to 1.82

0.34

Issued under Private Placements

500,786

0.5

0.01

Reclassified from non-employee

810,000

0.50 to 0.75

Exercised

(250,000

)

0.04

Expired

Outstanding, December 31, 2012

17,258,644

.04 to 1.82

0.48

Granted

2,802,500

0.99 to 2.92

0.26

Reclassified to non-employee, net

(235,000

)

0.50 to 2.30

0.02

Exercised

(2,816,667

)

0.04 to 0.75

0.01

Expired/terminated

(245,000

)

0.50 to 2.92

Outstanding, September 30, 2013

16,764,477

$.04 to $2.40

0.7

Exercisable, September 30, 2013

9,315,310

$.04 to $2.30

0.4

Weighted Average Remaining Life,

Exercisable, September 30, 2013 (years)

1.8

Non-Employee Grants

On January 2, 2012, the Company issued a consultant an option to purchase 250,000 shares of the Company's common stock at $.50 per share. These options have been valued at $51,692 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.2%, risk free interest rate of 0.9% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed when the service is provided.

On January 17, 2012, the Company issued a consultant an option to purchase 200,000 shares of the Company's common stock at $.50 per share. These options have been valued at $31,437, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 28.0%, risk free interest rate of 0.8% and expected option life of five years. The options expire five years from the date of issuance. Options granted were expensed immediately.

On March 31, 2012, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company's common stock at $.65 per share. These options have been valued at $18,947, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years. The options expire five years from the date of issuance. Options granted were expensed immediately.

On April 1, 2012, the Company issued a company owned by the former manager of corporate development an option to purchase 250,000 shares of the Company's common stock at $.70 per share pursuant to an agreement that also required a cash payment of $150,000. These options have been valued at $43,028, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years. The options expire five years from the date of issuance. Options granted were expensed through May 31, 2013, the term of the agreement.

In May 2012, the Company issued a consultant options to purchase an aggregate of 100,000 shares of the Company's common stock at an exercise price of $2.17 per share. These options were valued at $79,978 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of .75% and expected option life of five years. The options expire five years from the date of issuance. Options granted were expensed immediately.

In July 2012, the Company issued a consultant options to purchase an aggregate of 100,000 shares of the Company's common stock at an exercise price of $1.55 per share. These options were valued at $40,373 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.3%, risk free interest rate of .64% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed when the services are provided.

In August 2012, the Company issued two consultants options to purchase an aggregate of 400,000 shares of the Company's common stock at exercise prices ranging from $.35 to $1.11 per share. These options were valued at $321,221, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 27.1% to 30.5%, risk free interest rate of .27% to .67% and expected option lives of from two to five years. The options expire between two and five years from the date of issuance. Options granted are expensed when the services are provided.

In September 2012, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $.75 per share. These options were valued at $81,697, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of .27% and expected option life of two years. The options expire two years from the date of issuance. Options granted are expensed when the service is provided.

In October 2012, the Company issued a consultant options to purchase 50,000 shares of the Company's common stock at an exercise price of $.75 per share. These options were valued at $5,381, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5%, risk free interest rate of .19% and expected option life of one year. The options expire one year from the date of issuance. The options granted are expensed when the service was provided.

In November 2012, the Company issued four consultants options to purchase an aggregate of 765,000 shares of the Company's common stock at an exercise price of $1.01 per share. These options were valued at $188,830, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.1%, risk free interest rate of .76% and expected option life of five years. The options expire five years from the date of issuance. Options granted were expensed immediately.

In December 2012, the Company issued a merchant warrants to purchase 500,000 shares of the Company's common stock at an exercise price of $1.15 per share. The vesting of these warrants was predicated on meeting certain milestones. As of December 31, first milestone was met resulting in the vesting of 150,000 warrants. The fair value of the vested warrants was $58,595, which was expensed immediately. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.7%, risk free interest rate of .76% and expected option life of one year. As of September 30, 2013, the remaining milestones were met which provided vesting of the remaining 350,000 warrants. The fair value of these warrants was $549,915, which was expensed immediately. The warrants expire five years from the date of issuance.

In January 2013, the Company issued a consultant options to purchase 5,000 shares of the Company's common stock at an exercise price of $1.00 per share. These options were valued at $1,106 fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.3%, risk free interest rate of .78% and expected option life of five years. The options expire five years from the date of issuance. Options granted are expensed over the term of the agreement.

In March 2013, the Company issued two consultants options to purchase 1,130,000 shares of the Company's common stock at exercise prices of $0.75 and $1.48 per share. 130,000 of these options vested immediately and were valued at $54,228, fair value. The vesting of the remaining 1 million options is predicated on meeting certain milestones, which were not met as of September 30, 2013. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.6% and 25.5%, risk free interest rate of .25% and .80% and expected option life of two to five years. The options expire two to five years from the date of issuance. The vested options granted, were expensed immediately. The remaining unvested options will be expensed when it is probable that the milestones will be achieved.

In April 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $2.04 per share. These options were valued at $44,603, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.5%, risk free interest rate of .68% and expected option life of five years. The options expire five years from the date of issuance. Options granted were expensed immediately.

In May 2013, the Company issued two consultants options to purchase 125,000 shares in the aggregate of the Company's common stock at exercise prices ranging from $3.05 to $3.28 per share. These options were valued at $51,869, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.1% to 23.2%, risk free interest rate of .29% to .31% and expected option life of two years. The options expire two years from the date of issuance. Options granted are expensed over the term of the agreement.

In May 2013, the Company, as part of the cost of the Company's Offering described in Note 7, issued the placement agent warrants to purchase 287,255 shares of the Company's common stock at an exercise price of $1.80 per share. These warrants were valued at $409,749, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 23.4% to 23.7%, risk free interest rate of .49% and expected option life of three years. The warrants expire three years from the date of issuance. The warrants granted were recorded as stock issuance costs and reduced additional paid in capital.

In July 2013, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company's common stock at exercise prices ranging from $.75 to $2.61 per share. These options were valued at $124,338, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.8% to 26.6%, risk free interest rate of 1.35% to 1.66% and expected option life of five years. The options expire five years from the date of issuance. $124,338 was expensed immediately.

In September 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $1.17 per share. These options were valued at $26,208, fair value. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.1%, risk free interest rate of 1.39% and expected option life of five years. The options expire five years from the date of issuance. Options granted will be over the term of the agreement, which is three years.

Cumulatively and for the three and nine months ended September 30, 2013 and 2012, the Company expensed $1,803,849, $687,229 and $818,619 and for the three and nine months ended September 30, 2012 the Company expensed $142,086 and $203,593 relative to non-employee options/warrants granted. As of September 30, 2013, there was $90,984 of unrecognized compensation expense related to non-vested market-based share awards to non-employees.

The following table summarizes non-employee (excluding independent board members) stock options/warrants of the Company from December 31, 2011 to September 30, 2013 as follows:

Weighted Average

Option/Warrant

Exercise

Price

Outstanding, December 31, 2011

3,184,286

$0.04 to $2.30

0.76

Granted

2,915,000

0.35 to 2.17

0.12

Issued under Private Placement

11,967,152

0.50 to 1.00

0.38

Reclassified to employee

(810,000

)

0.50 to 0.75

Exercised

(350,000

)

0.04

Expired

(375,000

)

0.91 to 1.00

Outstanding, December 31, 2012

16,531,438

0.35 to 2.30

0.63

Granted

1,753,750

0.50 to 3.28

0.17

Issued under Private Placement

1,723,533

1.80 to 3.00

0.3

Reclassified from employee, net

235,000

0.50 to 2.30

0.02

Exercised

(2,995,185

)

.35 to .50

Expired/Cancelled

(1,405,000

)

0.50 to 1.00

Outstanding, September 30, 2013

15,843,536

$0.35 to $3.28

0.99

Exercisable, September 30, 2013

14,388,536

$0.50 to $3.28

0.93

Weighted Average Remaining Life,

Exercisable, September 30, 2013 (years)

1.4

OPERATING_LEASES

OPERATING LEASES	9 Months Ended
OPERATING LEASES	Sep. 30, 2013
OPERATING LEASES [Abstract]	'
OPERATING LEASES	'
	NOTE 9 - OPERATING LEASES

	For the three and nine months ended September 30, 2013, total rent expense under leases amounted to $117,447 and $244,318 and for the three and nine months ended September 30, 2012, total rent expense under leases amounted to $54,640 and $113,389. At September 30, 2013, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:


	2013		116,622
	2014		142,570
	2015		39,688

		$	298,880

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Sep. 30, 2013
RELATED PARTY TRANSACTIONS [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	NOTE 10 - RELATED PARTY TRANSACTIONS

	From inception through December 1, 2010, the Company utilized offices leased by affiliates of certain of the Company's board members without charge.

	During the three and nine months ended September 30, 2013 and 2012, a consultant and beneficial owner of the Company, owning more than five percent of the outstanding common shares of the Company, was paid for consulting and travel expenses to provide strategic advice to the Company. On January 1, 2013, the Company entered into an agreement with this consultant, whereby the Company would pay the consultant $12,500 per month beginning January 1, 2013 for a term of one year. In June 2013, this contract was terminated. Consulting fees paid during the three and nine months ended September 30, 2013 were $0 and $130,000 and $0 and $172,500 was paid for the three and nine months ended September 30, 2012. Reimbursable business expenses of $6,506 and $30,072 were paid during the three and nine months ended September 30, 2013, and $20,001 and $32,224 were paid during the three and nine months ended September 30, 2012.

	During the three and nine months ended September 30, 2013 and 2012, a marketing company owned by the Company's Secretary and his spouse was paid $0 and $14,560 respectively.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Comprehensive Income	'
	Comprehensive Income
	The Company follows FASB ASC 220 in reporting comprehensive income. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since the Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company's financial instruments consist of cash, accounts receivable and accounts payable and accrued expenses. The carrying value of cash, accounts receivable and accounts payable and accrued expenses approximate fair value, because of their short maturity.
Concentration of Credit Risk Involving Cash	'
	Concentration of Credit Risk Involving Cash
	The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance coverage of $250,000.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.
Property and Equipment	'
	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation and any impairment losses. Expenditures for new equipment and major expenditures for existing equipment are capitalized and depreciated using the straight line method at rates sufficient to depreciate such costs over the estimated productive lives. All other ordinary repair and maintenance costs are expensed as incurred.

	The Company's depreciation and amortization policies on property and equipment are as follows:


		Useful life
		(in years)

	Computer equipment	3 - 5
	Furniture and fixtures	7
Recoverability of Long-Lived Assets	'
	Recoverability of Long-Lived Assets
	In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 360-10-35 "Impairment or Disposal of Long-lived Assets", long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable or that the useful lives of those assets are no longer appropriate. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment.

	The Company determines the existence of such impairment by measuring the expected future cash flows (undiscounted and without interest charges) and comparing such amount to the carrying amount of the assets. An impairment loss, if one exists, is then measured as the amount by which the carrying amount of the asset exceeds the discounted estimated future cash flows. Assets to be disposed of are reported at the lower of the carrying amount or fair value of such assets less costs to sell. Asset impairment charges are recorded to reduce the carrying amount of the long-lived asset that will be sold or disposed of to their estimated fair values. Charges for the asset impairment reduce the carrying amount of the long-lived assets to their estimated salvage value in connection with the decision to dispose of such assets.

	For the nine month period ended September 30, 2013 and 2012, the Company determined that no impairment was required after going through the impairment testing related to the operating long-lived assets (property and equipment and patents and trademarks).
Revenue Recognition	'
	Revenue Recognition
	In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale utilizing Virtual Piggy payment method at checkout.
Income Taxes	'
	Income Taxes
	The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.
Loss Per Share	'
	Loss Per Share
	The Company follows FASB ASC 260 when reporting earnings per share resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss for the three and nine months ended September 30, 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same.
Start-up Costs	'
	Start-up Costs
	In accordance with FASB ASC 720, start-up costs are expensed as incurred.
Research and Development Costs	'
	Research and Development Costs
	In accordance with FASB ASC 730, research and development costs are expensed when incurred.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted	'
	Recently Adopted Accounting Pronouncements
	As of September 30, 2013 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.

	Recently Issued Accounting Pronouncements Not Yet Adopted
	As of September 30, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.
Reclassifications	'
	Reclassifications
	Certain amounts in the 2012 financial statements have been reclassified in order for them to be in conformity with the 2013 presentation.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Schedule of Property and Equipment, Useful Life	'
	The Company's depreciation and amortization policies on property and equipment are as follows:


		Useful life
		(in years)

	Computer equipment	3 - 5
	Furniture and fixtures	7

STOCK_OPTIONS_AND_WARRANTS_Tab

STOCK OPTIONS AND WARRANTS (Tables)	9 Months Ended
STOCK OPTIONS AND WARRANTS (Tables)	Sep. 30, 2013
STOCK OPTIONS AND WARRANTS [Abstract]	'
Summary of Stock Options and Warrant Transactions for Employees	'
	A summary of stock option/warrant transactions for employees and independent board members from December 31, 2011 to September 30, 2013 is as follows:


							Weighted Average
		Option/Warrants			Exercise		Exercise
		Shares			Price		Price
	Outstanding, December 31, 2011		9,467,858			$.04 to $.90	$	0.19

	Granted		6,730,000		0.50 to 1.82			0.34
	Issued under Private Placements		500,786			0.5		0.01
	Reclassified from non-employee		810,000		0.50 to 0.75			-
	Exercised		(250,000	)		0.04		-
	Expired		-			-		-

	Outstanding, December 31, 2012		17,258,644		.04 to 1.82			0.48

	Granted		2,802,500		0.99 to 2.92			0.26
	Reclassified to non-employee, net		(235,000	)	0.50 to 2.30			0.02
	Exercised		(2,816,667	)	0.04 to 0.75			0.01
	Expired/terminated		(245,000	)	0.50 to 2.92			-

	Outstanding, September 30, 2013		16,764,477			$.04 to $2.40	$	0.7

	Exercisable, September 30, 2013		9,315,310			$.04 to $2.30	$	0.4

	Weighted Average Remaining Life,
	Exercisable, September 30, 2013 (years)		1.8

Summary of Non-Employee Stock Options and Warrants	'
	The following table summarizes non-employee (excluding independent board members) stock options/warrants of the Company from December 31, 2011 to September 30, 2013 as follows:

							Weighted Average
		Option/Warrant			Exercise		Exercise
		Shares			Price		Price
	Outstanding, December 31, 2011		3,184,286			$0.04 to $2.30	$	0.76

	Granted		2,915,000		0.35 to 2.17			0.12
	Issued under Private Placement		11,967,152		0.50 to 1.00			0.38
	Reclassified to employee		(810,000	)	0.50 to 0.75			-
	Exercised		(350,000	)		0.04		-
	Expired		(375,000	)	0.91 to 1.00			-

	Outstanding, December 31, 2012		16,531,438		0.35 to 2.30			0.63

	Granted		1,753,750		0.50 to 3.28			0.17
	Issued under Private Placement		1,723,533		1.80 to 3.00			0.3
	Reclassified from employee, net		235,000		0.50 to 2.30			0.02
	Exercised		(2,995,185	)	.35 to .50			-
	Expired/Cancelled		(1,405,000	)	0.50 to 1.00			-

	Outstanding, September 30, 2013		15,843,536			$0.35 to $3.28	$	0.99

	Exercisable, September 30, 2013		14,388,536			$0.50 to $3.28	$	0.93

	Weighted Average Remaining Life,
	Exercisable, September 30, 2013 (years)		1.4

OPERATING_LEASES_Tables

OPERATING LEASES (Tables)	9 Months Ended
OPERATING LEASES (Tables)	Sep. 30, 2013
OPERATING LEASES [Abstract]	'
Schedule of Future Minimum Rental Commitments Under Non-Cancelable Operating Lease Arrangements	'
	At September 30, 2013, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:


	2013		116,622
	2014		142,570
	2015		39,688

		$	298,880

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Number of merchant agreements with merchants to deploy technology on their websites	143
Number of merchants using technology in live use	20
FDIC insured limit	$250,000
Computer equipment [Member] \| Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Useful life	'3 years
Computer equipment [Member] \| Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Useful life	'5 years
Furniture and fixtures [Member]	'
Property, Plant and Equipment [Line Items]	'
Useful life	'7 years

GOING_CONCERN_Details

GOING CONCERN (Details) (USD $)	9 Months Ended		68 Months Ended
GOING CONCERN (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
GOING CONCERN [Abstract]	'	'	'
Amount raised from private placement	$6,070,595	'	'
Stock issuance costs	395,221	28,000	488,221
Proceeds from exercise of options	185,000	24,000	569,000
Proceeds from exercise of warrants	$1,427,595	'	$1,873,309

PATENTS_Details

PATENTS (Details) (Patents [Member], USD $)	3 Months Ended		9 Months Ended
PATENTS (Details) (Patents [Member], USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Patents [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Amortization period	'	'	'20 years	'
Unamortized capitalized patent costs	$604,572	$268,856	$604,572	$268,856
Amortization expense for patents	$7,718	$3,374	$19,617	$7,546

NOTES_PAYABLE_Details

NOTES PAYABLE (Details) (USD $)

9 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

Sep. 30, 2013

Dec. 31, 2012

Apr. 30, 2012

Feb. 29, 2012

Feb. 08, 2012

Dec. 31, 2011

Sep. 30, 2011

Dec. 31, 2012

Dec. 31, 2011

Sep. 30, 2011

Dec. 31, 2011

Sep. 30, 2011

Private Placement, September 2011 to December 2011 [Member]

Warrant [Member]

Common Stock [Member]

Notes Payable Equity Issuance [Line Items]

Units authorized

Price per unit

$50,000

Note payable included per unit

$50,000

Note payable maturity date

12-Nov-12

Number of shares entitled by warrants

15,000

Exercise price of warrants

0.5

Warrants/Options expiration date

12-Nov-12

Common shares issued per unit

111,386,768

101,417,508

15,000

Amount raised from private placement

6,070,595

500,000

Fair value of issued equity

20,930

82,655

Pricing model used in calculation of grant-date fair value

'Black-Scholes option pricing model

Dividend yield

Expected volatility, minimum

39.80%

Expected volatility, maximum

62.80%

Risk free interest rate

0.10%

Expected life

'1 year 2 months 12 days

Fair value per share, common stock, minimum

$0.45

Fair value per share, common stock, maximum

$0.70

Accreted interest on notes payable

65,560

38,035

Repayments of notes payable

25,000

50,000

100,000

150,000

Accrued interest payable

$25,000

Common shares issued for notes payable conversion

571,428

Fair value of warrants issued as discount for notes payable

285,714

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	3 Months Ended		9 Months Ended
INCOME TAXES (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
INCOME TAXES [Abstract]	'	'	'	'
Income tax expense	'	'	'	'

LITIGATION_SETTLEMENT_Details

LITIGATION SETTLEMENT (Details) (USD $)	12 Months Ended
LITIGATION SETTLEMENT (Details) (USD $)	Dec. 31, 2012
LITIGATION SETTLEMENT [Abstract]	'
Cash payment for settlement	$450,000
Proceeds from insurance carrier	$75,000

STOCKHOLDERS_EQUITY_Details

STOCKHOLDERS' EQUITY (Details) (USD $)

9 Months Ended

12 Months Ended

68 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

11 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

2 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Sep. 30, 2013

Jan. 31, 2012

Dec. 31, 2011

Mar. 31, 2012

Apr. 30, 2012

Sep. 30, 2012

Apr. 30, 2012

31-May-12

Mar. 31, 2013

31-May-12

Aug. 31, 2012

Jul. 31, 2012

Dec. 31, 2012

Mar. 31, 2013

Apr. 30, 2013

31-May-13

Jun. 30, 2013

Aug. 31, 2013

December 2011 Private Placement [Member]

April 5, 2012 Private Placement [Member]

April 2, 2012 Issuance [Member]

April 10, 2012 Issuance [Member]

May 2, 2012 Issuance [Member]

May 21, 2012 Issuance [Member]

May 25, 2012 Issuance [Member]

July 5th, 2012 Issuance [Member]

November and December 2012 Issuance [Member]

December 2012 Issuance [Member]

Q1 2013 Issuance [Member]

April 15, 2013 Issuance [Member]

May 2013 Securities Purchase Agreement [Member]

May 2013 Options Exercised [Member]

May 2013 Options Exercised Transaction One [Member]

May 2013 Options Exercised Transaction Two [Member]

May 2013 Options Exercised Transaction Three [Member]

May and June 2013 Warrants Exercised [Member]

May and June 2013 Warrants Exercised Transaction One [Member]

May and June 2013 Warrants Exercised Transaction Two [Member]

July and August 2013 Warrants Exercised [Member]

Warrant Type One [Member]

Warrant Type Two [Member]

Warrant Type One [Member]

Warrant Type Two [Member]

Restricted Stock [Member]

Warrant Type One [Member]

Warrant Type Two [Member]

Equity Issued [Line Items]

Issuance of shares of common stock, shares

178,572

1,363,185

26,521

Issuance of shares of common stock, value

$3,312,537

$49,071

Equity issuance, price or exercise price per security issued

$0.70

$0.80

$0.70

$0.85

$0.80

$2.43

$0.80

$0.70

$0.75

$1.80

$0.04

$0.35

$0.75

Proceeds from equity issuance

2,717,650

150,000

100,000

5,560,000

500,000

850,000

Units authorized

7,142,858

6,250,000

Shares per unit

Warrants per unit

Number of shares entitled by warrants

6,250,000

5,000,000

0.5

125,000

62,500

0.5

287,255

Exercise price of warrants

0.5

1.8

0.04

0.5

Expected life

'2 years

'3 years

'2 years

'3 years

'5 years

Equity issuance, number securities issued for cash

625,000

3,922,356

6,201,831

350,000

250,000

187,500

350,000

125,000

7,942,858

666,667

1,133,334

2,572,553

300,000

750,000

300,000

66,667

Amount raised from private placement

6,070,595

500,000

4,341,282

297,500

10,000

850,000

14,000

100,000

4,836,157

Warrants issued

89,286

Proceeds from exercise of options

185,000

24,000

569,000

185,000

Warrants exercised

2,000,000

2,660,685

34,500

Proceeds from exercise of warrants

1,427,595

1,873,309

1,330,342

17,250

Stock issuance costs including commisions

395,221

28,000

488,221

28,000

60,783

Common stock subscription

50,000

Common stock authorized in private placement, value

5,000,000

3,500,000

4,000,000

Common stock authorized in private placement, shares

12,500,000

10,000,000

Warrants authorized in private placement

6,250,000

Cash payment for settlement

450,000

30,000

Value of shares covered in agreement

1,000,000

Options issued

1,050,000

Fair value of issued equity

519,080

Pricing model used in calculation of grant-date fair value

'Black-Scholes option pricing model

Dividend yield

Expected volatility

29.00%

Risk free interest rate

0.69%

Vesting period

'3 years

Expiration period after issuance

'5 years

Placement agent fees

151,408

Expense allowance

$155,118

STOCK_OPTIONS_AND_WARRANTS_Det

STOCK OPTIONS AND WARRANTS (Details) (USD $)

9 Months Ended

3 Months Ended

9 Months Ended

68 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

68 Months Ended

1 Months Ended

Sep. 30, 2013

Dec. 31, 2008

Sep. 30, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Jan. 31, 2012

Feb. 29, 2012

Mar. 31, 2012

Apr. 30, 2012

Jun. 30, 2012

Jul. 31, 2012

Aug. 31, 2012

Sep. 30, 2012

Oct. 31, 2012

Nov. 30, 2012

Jan. 31, 2013

Mar. 31, 2008

Jan. 31, 2013

Feb. 28, 2013

Mar. 31, 2013

Apr. 30, 2013

31-May-13

Jun. 30, 2013

Aug. 31, 2013

Sep. 30, 2013

Dec. 31, 2012

Dec. 31, 2011

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Jan. 31, 2012

Mar. 31, 2012

Apr. 30, 2012

31-May-12

Jul. 31, 2012

Aug. 31, 2012

Sep. 30, 2012

Oct. 31, 2012

Nov. 30, 2012

Sep. 30, 2013

Dec. 31, 2012

Jan. 31, 2013

Mar. 31, 2013

Apr. 30, 2013

31-May-13

Jul. 31, 2013

Sep. 30, 2013

2008 Equity Incentive Plan [Member]

2013 Equity Incentive Plan [Member]

Incentive Stock Options [Member]

Non-Statutory Stock Options [Member]

Options issued to employees [Member]

January 27, 2012 Options Issued to Employees [Member]

February 28, 2012 Options Issued to Employees [Member]

March 2, 2012 Options Issued to Employees [Member]

March 5, 2012 Options Issued to Employees [Member]

March 31, 2012 Options Issued to Employees [Member]

April 2012 Options Issued to Employees [Member]

June 2012 Options Issued to Employees [Member]

July 2012 Options Issued to Employees [Member]

August 2012 Options Issued to Employees [Member]

September 2012 Options Issued to Employees [Member]

October 2012 Options Issued to Employees [Member]

November 2012 Options Issued to Employees [Member]

March 2008 Options Issued to Directors [Member]

January 2013 Options Issued to Employees [Member]

February 2013 Options Issued to Employees [Member]

March 2013 Options Issued to Employees [Member]

April 2013 Options Issued To Employees [Member]

May 2013 Options Issued To Employees [Member]

June 2013 Options Issued To Employees [Member]

August 2013 Options Issued To Employees [Member]

September 2013 Options Issued To Employees [Member]

Options issued to non-employees [Member]

January 2, 2012 Options Issued to Consultants [Member]

January 17, 2012 Options Issued to Consultants [Member]

March 31, 2012 Options Issued to Consultants [Member]

April 1, 2012 Options Issued to Consultants [Member]

May 2012 Options Issued to Consultants [Member]

July 2012 Options Issued to Consultants [Member]

August 2012 Options Issued to Consultants [Member]

September 2012 Options Issued to Consultants [Member]

October 2012 Options Issued to Consultants [Member]

November 2012 Options Issued to Consultants [Member]

December 2012 Options Issued To Consultants [Member]

January 2013 Options Issued to Consultants [Member]

March 2013 Options Issued To Consultants [Member]

April 2013 Options Issued To Consultants [Member]

May 2013 Options Issued To Consultants [Member]

May 2013 Options Issued for Private Placement [Member]

July 2013 Options Issued To Consultants [Member]

September 2013 Options Issued To Consultants [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options authorized

25,000,000

5,000,000

Outstanding options

14,053,000

3,702,500

16,764,477

17,258,644

9,467,858

4,250,000

15,843,536

16,531,438

3,184,286

Options available to be issued

61,667

1,297,500

Percent of fair market value of common stock the exercise price of options may not exceed

100.00%

Percent of fair market value of common stock the exercise price may not exceed, when grantee holds greater than 10% shares outstanding

110.00%

Grantee ownership percentage considered in determination of options exercise price

10.00%

Options issued

30,000

25,000

250,000

25,000

4,010,000

80,000

470,000

15,000

380,000

75,000

1,295,000

4,500,000

260,000

760,000

2,500

200,000

55,000

210,000

10,000

250,000

200,000

100,000

250,000

100,000

400,000

100,000

50,000

765,000

500,000

5,000

130,000

100,000

125,000

287,255

100,000

Minimum option exercise price

$0.65

$1.53

$1.26

$1.01

$0.99

$1.07

$2.16

$2.40

$0.35

$0.75

$3.05

$0.75

Option exercise price

$0.52

$0.58

$0.65

$1.23

$1.54

$1.35

$1.36

$1.56

$1.97

$0.50

$0.65

$0.70

$2.17

$1.55

$0.75

$1.01

$1.15

$2.04

$1.80

$1.17

Maximum option exercise price

$0.97

$1.82

$1.43

$1.35

$1.05

$1.21

$2.29

$2.92

$2.35

$1.11

$1.48

$3.28

$2.61

Fair value of issued equity

$210,380

$81,588

$546,776

$274,757

$1,446,783

$3,718

$3,120

$33,975

$2,680

$759,810

$17,310

$217,293

$5,493

$123,381

$26,303

$23,263

$371,313

$62,662

$199,843

$728

$74,159

$26,954

$129,343

$124,392

$4,500

$687,229

$142,086

$818,619

$203,593

$1,803,849

$51,692

$31,437

$18,947

$43,028

$79,978

$40,373

$321,221

$81,697

$5,381

$188,830

$1,106

$54,228

$44,603

$51,869

$409,749

$124,338

$26,208

Pricing model used in calculation of grant-date fair value

'Black-Scholes option pricing model

'Black-Scholes option pricing mode

'Black-Scholes option pricing model

Dividend yield

Expected volatility

25.40%

25.00%

25.90%

25.00%

31.20%

32.90%

24.50%

22.50%

25.30%

21.80%

29.20%

28.00%

31.20%

29.30%

25.60%

23.50%

26.10%

24.70%

23.30%

26.50%

22.10%

Risk free interest rate

0.80%

0.90%

1.04%

0.61%

0.62%

0.70%

0.76%

1.71%

0.90%

0.80%

1.04%

0.75%

0.64%

0.27%

0.19%

0.76%

0.78%

0.68%

0.49%

1.39%

Expected life

'5 years

'2 years

'5 years

'2 years

'1 year

'5 years

'1 year

'5 years

'2 years

'5 years

'2 years

'3 years

'5 years

Expiration period after issuance

'5 years

'2 years

'5 years

'2 years

'1 year

'5 years

'2 years

'5 years

'2 years

'3 years

'5 years

Senior Vice President of Marketing and Licensing annual compensation

150,000

Vesting period

'3 years

Expected volatility, minimum

30.20%

30.30%

23.50%

26.10%

23.30%

22.50%

23.50%

23.60%

24.20%

27.10%

22.60%

23.10%

23.40%

23.80%

Expected volatility, maximum

33.40%

35.50%

29.10%

29.30%

26.10%

25.10%

25.30%

26.30%

30.30%

30.50%

25.50%

23.20%

23.70%

26.60%

Risk free rate, minimum

0.82%

0.68%

0.63%

0.76%

0.78%

0.84%

1.03%

1.38%

0.27%

0.25%

0.29%

1.35%

Risk free rate, maximum

1.04%

0.72%

0.69%

0.83%

0.89%

0.88%

0.85%

1.48%

1.61%

0.67%

0.80%

0.31%

1.66%

Share-based compensation

124,338

Unrecognized compensation expense

1,746,505

90,984

Incremental increase in value

1,253

Warrants vested

350,000

150,000

Value of vested warrants

$549,915

$58,595

Aggregate options issued

250,000

1,130,000

Options issued, excluded from valuation

50,000

1,000,000

STOCK_OPTIONS_AND_WARRANTS_Inc

STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) (Incentive Stock Options [Member], USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Option/Warrants Shares	'	'
Outstanding, shares, beginning of period	17,258,644	9,467,858
Granted, shares	2,802,500	6,730,000
Issued under Private Placements, shares	'	500,786
Reclassified from (to) non-employee, shares	-235,000	810,000
Exercised, shares	-2,816,667	-250,000
Expired/terminated, shares	-245,000	'
Outstanding, shares, end of period	16,764,477	17,258,644
Exercise Price	'	'
Issued under Private Placements, exercise price	'	$0.50
Exercised, exercise price	'	$0.04
Expired/terminated, exercise price	'	'
Weighted Average Exercise Price	'	'
Outstanding, weighted average exercise price, beginning of period	$0.48	$0.19
Granted, weighted average exercise price	$0.26	$0.34
Issued under Private Placements, weighted average exercise price	'	$0.01
Reclassified from/to non-employee, weighted average exercise price	$0.02	'
Exercised, weighted average exercise price	$0.01	'
Expired/terminated, weighted average exercise price	'	'
Outstanding, weighted average exercise price, end of period	$0.70	$0.48
Exercisable, shares, September 30, 2013	9,315,310	'
Exercisable, weighted average exercise price, September 30, 2013	$0.40	'
Weighted Average Remaining Life, Exercisable, September 30, 2013 (years)	'1 year 9 months 18 days	'
Minimum [Member]	'	'
Exercise Price	'	'
Outstanding, exercise price, beginning of period	$0.04	$0.04
Granted, exercise price	$0.99	$0.50
Reclassified from/to non-employee, exercise price	$0.50	$0.50
Exercised, exercise price	$0.04	'
Expired/terminated, exercise price	$0.50	'
Outstanding, exercise price, end of period	$0.04	$0.04
Weighted Average Exercise Price	'	'
Exercisable, exercise price, September 30, 2013	$0.04	'
Maximum [Member]	'	'
Exercise Price	'	'
Outstanding, exercise price, beginning of period	$1.82	$0.90
Granted, exercise price	$2.92	$1.82
Reclassified from/to non-employee, exercise price	$2.30	$0.75
Exercised, exercise price	$0.75	'
Expired/terminated, exercise price	$2.92	'
Outstanding, exercise price, end of period	$2.40	$1.82
Weighted Average Exercise Price	'	'
Exercisable, exercise price, September 30, 2013	$2.30	'

STOCK_OPTIONS_AND_WARRANTS_Non

STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) (Non Statutory Stock Options [Member], USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Option/Warrant Shares	'	'
Outstanding, shares, beginning of period	16,531,438	3,184,286
Granted, shares	1,753,750	2,915,000
Issued under Private Placement, shares	1,723,533	11,967,152
Reclassified from (to) employee, shares	235,000	-810,000
Exercised, shares	-2,995,185	-350,000
Expired, shares	-1,405,000	-375,000
Outstanding, shares, end of period	15,843,536	16,531,438
Exercise Price	'	'
Exercised, exercise price	'	$0.04
Weighted Average Exercise Price	'	'
Outstanding, weighted average exercise price, beginning of period	$0.63	$0.76
Granted, weighted average exercise price	$0.17	$0.12
Issued under Private Placement, weighted average exercise price	$0.30	$0.38
Reclassified from/to employee, weighted average exercise price	$0.02	'
Exercised, weighted average exercise price	'	'
Expired, weighted average exercise price	'	'
Outstanding, weighted average exercise price, end of period	$0.99	$0.63
Exercisable, shares, September 30, 2013	14,388,536	'
Exercisable, weighted average exercise price, September 30, 2013	$0.93	'
Weighted Average Remaining Life, Exercisable, September 30, 2013 (years)	'1 year 4 months 24 days	'
Minimum [Member]	'	'
Exercise Price	'	'
Outstanding, exercise price, beginning of period	$0.35	$0.04
Granted, exercise price	$0.50	$0.35
Issued under Private Placement, exercise price	$1.80	$0.50
Reclassified from/to employee, exercise price	$0.50	$0.50
Exercised, exercise price	$0.35	'
Expired, exercise price	$0.50	$0.91
Outstanding, exercise price, end of period	$0.35	$0.35
Weighted Average Exercise Price	'	'
Exercisable, exercise price, September 30, 2013	$0.50	'
Maximum [Member]	'	'
Exercise Price	'	'
Outstanding, exercise price, beginning of period	$2.30	$2.30
Granted, exercise price	$3.28	$2.17
Issued under Private Placement, exercise price	$3	$1
Reclassified from/to employee, exercise price	$2.30	$0.75
Exercised, exercise price	$0.50	'
Expired, exercise price	$1	$1
Outstanding, exercise price, end of period	$3.28	$2.30
Weighted Average Exercise Price	'	'
Exercisable, exercise price, September 30, 2013	$3.28	'

OPERATING_LEASES_Details

OPERATING LEASES (Details) (USD $)	3 Months Ended		9 Months Ended
OPERATING LEASES (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
OPERATING LEASES [Abstract]	'	'	'	'
Total rent expense under leases	$117,447	$54,640	$244,318	$113,389

OPERATING_LEASES_Schedule_of_N

OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) (USD $)	Sep. 30, 2013
OPERATING LEASES [Abstract]	'
2013	$116,622
2014	142,570
2015	39,688
Total	$298,880

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details) (USD $)	3 Months Ended		9 Months Ended
RELATED PARTY TRANSACTIONS (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Related Party Transaction [Line Items]	'	'	'	'
Related party expenses	$6,506	$20,001	$30,072	$32,224
Monthly payment for consulting services per agreement	'	'	12,500	'
Consultant and Beneficial Owner [Member]	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Related party expenses	'	'	130,000	172,500
Marketing Company Owned by Secretary [Member]	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Related party expenses	'	$14,560	'	$14,560